Sarepta Therapeutics Inc. (SRPT)

132.05
NASDAQ : Health Technology
Prev Close 100.47
Day Low/High 125.50 / 138.79
52 Wk Low/High 72.05 / 158.80
Avg Volume 1.30M
Exchange NASDAQ
Shares Outstanding 74.54M
Market Cap 7.49B
EPS -5.50
Div & Yield N.A. (N.A)

Latest News

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.

Sarepta Therapeutics Looks Ready to Break Out to the Upside

Sarepta Therapeutics Looks Ready to Break Out to the Upside

Here's how to play this stock.

Hopeful Signs for These 2 Small Biotech Stocks

Hopeful Signs for These 2 Small Biotech Stocks

Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.

Is This Market Action Foreshadowing Something Worse?

Is This Market Action Foreshadowing Something Worse?

This trading is starting to create some fairly deep pullbacks.

Sarepta Therapeutics' Charts Look Risky

Sarepta Therapeutics' Charts Look Risky

In a red flag for investors, the charts show sellers are getting more aggressive with Sarepta.

You've Got to Ask Yourself One Question: 'Do I Feel Lucky?'

You've Got to Ask Yourself One Question: 'Do I Feel Lucky?'

Luck is our constant companion in the stock market and we are fools if we ignore that fact.

The Bears Now Have Possession of the Ball After Bulls Fumble It Away

The Bears Now Have Possession of the Ball After Bulls Fumble It Away

Can they finally put some points on the board?

Fear of Missing Out Is the Main Driving Force in This Market

Fear of Missing Out Is the Main Driving Force in This Market

Stick to your methodology and don't let worry of underperformance push you to shift your approach.

The Market Is Transitioning Back to Stock Picking

The Market Is Transitioning Back to Stock Picking

There are obvious signs that people are trying to put cash to work.

Quiet Trading Allowing Some Biotech Names to Perk Up

Quiet Trading Allowing Some Biotech Names to Perk Up

After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life.

Netflix Is Tonight's Big Report: Here's How I Would Play It

Netflix Is Tonight's Big Report: Here's How I Would Play It

This is a battleground stock that has made big moves in both directions on earnings in the past.

The Market Is Not Embracing JPMorgan's Optimism

The Market Is Not Embracing JPMorgan's Optimism

The pressure on financials is affecting the entire market.

Square Continues to See Extreme Pressure

Square Continues to See Extreme Pressure

If you are interested in Square longer term be patient and wait for the drama to end.

Intel Regains Its Leadership Position in the Semiconductor Sector

Intel Regains Its Leadership Position in the Semiconductor Sector

The stock still needs to do more work to be convincing.

Overall Market Breadth Remains Negative

Overall Market Breadth Remains Negative

I'm not yet convinced that this poor action is the start of a major change in market character.

PepsiCo Isn't Going Anywhere Soon

PepsiCo Isn't Going Anywhere Soon

Blue chip name PEP is a good example of the weak action in individual stocks.

There's Nothing Very Attractive About GE

There's Nothing Very Attractive About GE

It's an interesting story but there are better places for your funds.

Sarepta Rated New Overweight at Cantor

Play Sarepta Therapeutics' Climb This Way

Play Sarepta Therapeutics' Climb This Way

This options trade gives the position plenty of time to work.

Alphabet Before Congress, Fed Decision Make for an Interesting Day

Alphabet Before Congress, Fed Decision Make for an Interesting Day

Traders are likely remembering what Facebook stock did when Mark Zuckerberg testified before Congress.

Sears Has Become a Disaster

Sears Has Become a Disaster

It is the poster boy for the havoc that internet retailers have wrecked on brick and mortar retailers.

Corrective Action in This Market Is Often Quite Hidden

Corrective Action in This Market Is Often Quite Hidden

The indices are being jerked around on some news headlines today.

There Is No Rush to Buy Micron

There Is No Rush to Buy Micron

It's not different this time, semiconductors are still cyclical.

Six Biotechnology Names on My Watch List

Six Biotechnology Names on My Watch List

After recent weakness in the biotech sector, here are some names to start watching.

The Market Is Finally Pulling Back

The Market Is Finally Pulling Back

This is a healthy pullback in a market that was a little overheated.

Coffee Acquisition or Not, Coca-Cola Doesn't Have Much Fizz

Coffee Acquisition or Not, Coca-Cola Doesn't Have Much Fizz

Despite $5.1 billion deal for Costa, I'm not slurping any KO up.

A Lesson to Learn From Thursday's Market Action

A Lesson to Learn From Thursday's Market Action

You don't have to be Sigmund Freud to understand the psychology here.

HPE: Surpassing Expectations, Raising Guidance Incrementally

HPE: Surpassing Expectations, Raising Guidance Incrementally

If estimates continue to come up there will be institutional interest in the stock.